Cerus to Present at the Wedbush 2014 Life Sciences Management Access Conference on August 12, 2014

2014 Wedbush Life Sciences Conference

CONCORD, Calif.--()--Cerus Corporation (NASDAQ:CERS) announced today that William “Obi” Greenman, president and chief executive officer, is scheduled to present a corporate update at the Wedbush 2014 Life Sciences Management Access Conference at 8:35 AM ET on Tuesday, August 12, 2014.

A live webcast of the presentation will be available from the Investor Relations page of the Cerus web site at http://www.cerus.com/ir. A replay will be available for approximately two weeks following the completion of the event.

ABOUT CERUS

Cerus Corporation is a biomedical products company focused in the field of blood safety. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. In the United States, Cerus is seeking regulatory approval of the INTERCEPT Blood System for plasma and platelets. The INTERCEPT red blood cell system is in clinical development. See http://www.cerus.com for more information.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

Contacts

Cerus Corporation
Lainie Corten, 925-288-6319
Senior Director, Global Marketing & Investor Relations

Contacts

Cerus Corporation
Lainie Corten, 925-288-6319
Senior Director, Global Marketing & Investor Relations